Szczepan B.

Szczepan B. serves as Chief Scientific Officer at VeriSIM Life, focusing on regulatory and translational strategy while managing biosimulation and scientific units. With additional roles as a Building the Business Case for Digital Endpoints Project Team Partner with the Digital Medicine Society, Advisory Board Member for BRIDGE Innovation & Business Development, and an ad hoc member of the Scientific Advisory Committee on Alternative Toxicological Methods, Szczepan contributes significantly to advancing medical product development and alternative testing methods. Previous experience includes leading various innovative animal technologies and compliance training initiatives at Novartis. Szczepan holds a VMD from the University of Pennsylvania and an MS in Comparative Physiology and Medicine from the University of Washington, among other qualifications.